cp-945598 2008 Pages on BioPortfolio:

BioPortfolio - CP-945598
cp-945598 2008 - BioPortfolio. ... Recent Search Terms used to find this page: dry bath | CP-945598 RAT ... http://www.bioportfolio.com/indepth/Baths.html. ...
http://www.bioportfolio.com/search/CP-945,598.html...

Biotechnology News regulatory 945598. cp. cb1. harnett. 8009 ...
CP-945598 is a selective antagonist of the cannabinoid type. ... EpiCept Corporation Reports Third Quarter 2008 Operating and Financial Results ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - cp-945598 2008
cp-945598 2008 - BioPortfolio. ... cp-945598 2008 Pages on BioPortfolio: ... BioPortfolio - cp-945598 2008 18.3.1 CP 945598 and Capromorelin 18.3.2 Axitinib
...
http://www.bioportfolio.com/search/cp-945598_2008.html...

Biotechnology News obesity trbovich. napodano. vivu. acomplia ...
to terminate its Phase III testing of investigational drug (CP-945598), ... PharmaBiz: Nov 7 2008 5:28AM Matching: obes cb1, Find similar documents ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - portable sitz bath
BioPortfolio - cp-945598 2008 BioPortfolio - portable sitz bath Baths - BioPortfolio - Indepth. ... find ... Recent Search Terms used to find this page:
...
http://www.bioportfolio.com/search/portable_sitz_bath.html...

Biotechnology News new drug class acomplia. cb1. sanofi. aventi ...
to terminate its Phase III testing of investigational drug (CP-945598), ... Corante: Nov 7 2008 1:52AM Matching: drug class acomplia sanofi aventi 945598
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - CP-945598 RAT
7 Nov 2008 ... of scopolin in rat plasma: application to pharmacokinetic studies . ... drug (CP-945598), but it's still too early to tell if it's an. ...
http://www.bioportfolio.com/search/CP-945598_RAT.html...

Biotechnology News Vivus Search
to terminate its Phase III testing of investigational drug (CP-945598), but it's still .... VIVUS Announces Date of Third Quarter 2008 Financial Results and ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - CP-945598
cp-945598 2008 - BioPortfolio. ... CP-945598 123 Qnexa 123 Discontinued obesity drug candidates 125 Conclusion 132 ... Figure 4.5: Comparison of leading . ...
http://www.bioportfolio.com/search/CP-945598.html...

Biotechnology News new drug class trbovich. napodano. vivu ...
to terminate its Phase III testing of investigational drug (CP-945598), but it's still too ... PharmaBiz: Nov 7 2008 5:28AM Matching: new drug class cb1 ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Results from other life science and pharmaceutical sites:

News: Pfizer Discontinues Development Program for Its Phase 3 ...
CP-945598 is a selective antagonist of the cannabinoid type 1 (CB1) receptor. .... 2008 Genetic Engineering & Biotechnology News, All Rights Reserved ...
http://www.genengnews.com/news/bnitem.aspx?name=44888149&chi...

AltaVista - News results for: investigational
CP-945598 is a selective antagonist of the cannabinoid type 1 receptor. Pharmaceutical Business Review Thu, November 6, 2008 17:43 PM GMT Translate •
More ...
http://www.altavista.com/news/results?nc=7&nd=3&nr=0&q=inves...

Pfizer Discontinues Development Program for Its Phase 3 Obesity ...
NEW YORK--(BUSINESS WIRE)--Pfizer, Inc announced today that it is terminating the phase 3 development program for its investigational compound (CP-945598) ...
http://biz.yahoo.com/bw/081105/20081105006339.html?.v=1...

BioPortfolio - CP pharmaceuticals
Development Program For Its Phase 3 Obesity Compound (CP-945598) ... Acura Pharmaceuticals, Inc. Reports Third Quarter 2008 Financial Results . ...
http://www.bioportfolio.com/search/CP_pharmaceuticals.html...

Pfizer Inc. Ends Development of Obesity Drug - News, Search Jobs ...
11/6/2008 NEW YORK--(BUSINESS WIRE)--Pfizer, Inc announced today that it ... CP- 945598 is a selective antagonist of the cannabinoid type 1 (CB1) receptor. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=116113...

BioPortfolio - casopitant 2008
BioPortfolio - cp-945598 2008 BioPortfolio - http://www.google.com/search?as q= casopitant 2008 http://www. google.com/search?as q=casopitant 2008 ...
http://www.bioportfolio.com/search/casopitant_2008.html...

Health Highlights: Nov. 8, 2008 - Beth Israel Deaconess Medical Center
8, 2008. Here are some of the latest health and medical news developments, ... The experimental drug -- dubbed CP-945598 -- was in the third of three stages
...
http://www.bidmc.harvard.edu/YourHealth/HealthInTheNews.aspx...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.